Gene-edited pancreatic cells have been transplanted into a patient with type 1 diabetes for the first time. They produced ...

VedaBio has entered into agreement with Mammoth Biosciences to enhance its CRISPR-based molecular detection platform for ...

Horses with genomic edits to make them run faster have been banned from polo, but a zoo of CRISPR-edited animals is gaining ...

In this article, we will be taking a look at the 11 Best Performing Biotech Stocks So Far in 2025. CRISPR Therapeutics AG ...

A study, published in the journal Frontiers in Genome Editing, outlines a method for editing single plant cells from sterile ...

The new system developed by Professor Chad Mirkin delivers CRISPR machinery more safely and effectively into cells.

Edits create cells that don’t trigger an immune response, allowing implant recipient to forego immune-suppressing drugs.

CRISPR Therapeutics AG ( NASDAQ: CRSP) H.C. Wainwright 27th Annual Global Investment Conference September 8, 2025 4:30 PM EDT ...

Researchers developed TESLA-seq, a CRISPR-based method to map DNA regions that regulate genes. By scanning thousands of ...

More than a decade ago, scientists harnessed a bacterial molecular machine that identifies and cuts specific sections of DNA, ...

It has long been understood that orchard automation is the key for industry’s profitability and sustainability. As part of ...

VedaBio, a pioneering biotechnology company transforming molecular detection, today announced a non-exclusive license agreement with Mammoth Biosciences, Inc. for the use of select CRISPR-based ...